While Intrathecal Pumps can be effective at managing chronic pain and spasticity, they are not without risks. Complications can occur with the implantation of the pump, such as infection or bleeding. There is also a risk of complications with the catheter, such as migration or blockage, which can affect the delivery of medication. There is also a risk of overdose with intrathecal drug delivery. Because the medication is delivered directly into the spinal cord, it can be more potent than oral medications.
Patients who are receiving Intrathecal Pumps must be closely monitored to ensure that they are receiving the correct dose of medication. Patients who are considering intrathecal drug delivery should be evaluated by a pain management specialist or neurologist who has experience with this type of treatment. The specialist can help determine if intrathecal drug delivery is an appropriate treatment option and can provide guidance on the risks and benefits of the procedure.
